Acute Stroke Care in Illinois
- 1 May 2002
- journal article
- research article
- Published by Wolters Kluwer Health in Stroke
- Vol. 33 (5) , 1334-1340
- https://doi.org/10.1161/01.str.0000014609.44258.ad
Abstract
Background and Purpose — To define areas for quality improvement in acute stroke care, a statewide assessment of preparedness for acute stroke diagnosis and treatment was carried out among 202 acute receiving hospitals in Illinois. Methods — Medical directors or their designees completed a 1-page survey form that addressed availability of personnel, diagnostic technology, and organized programs for the treatment of acute stroke patients at their facility. In the analysis, acute care receiving hospitals in the Greater Chicago Metropolitan Area (GCMA) (Cook, Dupage, Lake, Will, and Kane counties) were compared with those in the remainder of the state. Results — Of the acute care receiving hospitals, 91% responded to the survey. Overall, 99% had an emergency room receiving facility, 98.3% had a CT scanner, and slightly >70% had a recombinant tissue plasminogen activator (r-TPA) protocol. We found that 93.2% of residents in Illinois lived in a county with at least 1 acute care facility with an r-TPA treatment protocol. However, many of the non-GCMA receiving hospitals did not have a neurologist or a neurosurgeon available. Furthermore, specialized stroke diagnostic technology (eg, transcranial Doppler, diffusion-weighted MRI, MR angiography) was generally lacking in both the GCMA and non-GCMA, as were stroke community awareness programs and acute care stroke teams. Conclusions — Stroke is a preventable and treatable disease. However, there are barriers to stroke care that are based on the availability of personnel, diagnostic technology, and programs. A systematic approach to the organization, implementation, and maintenance of services could improve outcome for stroke patients and reduce the public health burden of this deadly disease.Keywords
This publication has 14 references indexed in Scilit:
- Acute stroke care in non-urban emergency departmentsNeurology, 2001
- Intravenous Tissue-Type Plasminogen Activator Therapy for Ischemic StrokeArchives of Neurology, 2001
- Quality of Medical Care Delivered to Medicare BeneficiariesJAMA, 2000
- Recommendations for the Establishment of Primary Stroke CentersJAMA, 2000
- Neuroprotection in acute ischaemic stroke: a tale of for whom the bell tolls?The Lancet, 2000
- Use of Tissue-Type Plasminogen Activator for Acute Ischemic StrokeJAMA, 2000
- Prevention of a First StrokeJAMA, 1999
- NSA Stroke Center Network Stroke Center RecommendationsJournal Of Stroke & Cerebrovascular Diseases, 1997
- Collaborative systematic review of the randomised trials of organised inpatient (stroke unit) care after strokeBMJ, 1997
- Tissue Plasminogen Activator for Acute Ischemic StrokeNew England Journal of Medicine, 1995